Composition for reducing drug resistance of multi-drug-resistant escherichia coli and application thereof
The combination of quinox and scutellaria baicalensis jointly inhibits multidrug-resistant E. coli, which solves the problem of antibiotic resistance of the bacteria, significantly inhibits its growth and biofilm formation, improves the sensitivity to antibiotics, and provides an effective treatment plan. .
Patent Information
- Application Number
- CN202411180079.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-27
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2044-08-27
AI Technical Summary
Multidrug-resistant E. coli develops resistance to antibiotics, resulting in poor efficacy of conventional antibacterial drugs, and it is difficult for the prior art to effectively deal with such bacterial infections.
The composition of quinox and scutellaria baicalensis was used to synergistically inhibit E. coli through different mass ratios (0.12-0.49:7.8-62.5), reducing its resistance to antibiotics and inhibiting biofilm formation.
The combination of quinox and Scutellaria baicalensis significantly inhibits the growth and biofilm formation ability of multidrug-resistant E. coli, restores the bacteria's sensitivity to antibiotics, reduces drug resistance, and provides effective prevention and treatment methods.
Smart Images

Figure CN119055700A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of antimicrobial drug compositions, and particularly relates to a composition for reducing the drug resistance of multi-drug resistant Escherichia coli and an application thereof. Background Art
[0002] Antibiotics are of great significance for the prevention and treatment of various animal diseases. However, in recent years, the widespread use of antimicrobial drugs has led to a sharp increase in the number of multidrug-resistant bacteria. Long-term improper use of antibiotics can also lead to drug resistance, dysbacteriosis, and drug residues in the body. Escherichia coli is a Gram-negative bacterium belonging to the family Enterobacteriaceae and the genus Escherichia. Escherichia coli mainly inhabits the intestines of warm-blooded animals. Compared with Gram-positive bacteria, Gram-negative bacteria are more likely to develop drug resistance due to their special cell wall structure. Therefore, during the treatment of Escherichia coli, it is easy to develop resistance to antibiotics, resulting in poor treatment effects of conventional antimicrobial drugs. The increase in bacterial resistance has led to a weakening of the efficacy of antibiotics, and even treatment failures have occurred. Therefore, it is crucial to find new ways to deal with bacterial resistance or to reduce bacterial resistance to antibiotics to a certain extent. Summary of the invention
[0003] The invention provides a pharmaceutical composition for inhibiting Escherichia coli. The composition consists of gallnut and scutellaria baicalensis. The gallnut and astragalus can be selected from their decoctions respectively.
[0004] In the above composition, the mass ratio of the Chinese gallnut to the scutellaria baicalensis is selected from 0.12-0.49:7.8-62.5.
[0005] In a specific embodiment, the mass ratio of the Chinese gallnut to the scutellaria baicalensis can be 0.12:7.8, 0.12:31.25, 0.12:62.5 or 0.49:31.25.
[0006] The present invention provides application of the above composition in preparing a drug for synergistically inhibiting Escherichia coli.
[0007] In the above application, the Escherichia coli is a multidrug-resistant Escherichia coli, preferably Escherichia coli resistant to β-lactams, amidoalcohols, quinolones, aminoglycosides, sulfonamides, tetracyclines, polymyxins or chloramphenicol antibiotics; more preferably, Escherichia coli resistant to β-lactam antibiotics.
[0008] In the above application, the multidrug-resistant Escherichia coli is milk-derived multidrug-resistant Escherichia coli.
[0009] The present invention provides application of the above composition in preparing a medicine for synergistically inhibiting the formation of Escherichia coli biofilm.
[0010] The present invention provides application of the above composition in preparing a drug for reducing or eliminating drug resistance of Escherichia coli.
[0011] The present invention provides the use of the above composition in preparing a drug for improving the sensitivity of Escherichia coli to antibiotics; the antibiotics are selected from beta-lactams, amidoalcohols, quinolones, aminoglycosides, sulfonamides, tetracyclines, polymyxins or chloramphenicol antibiotics.
[0012] The invention provides a medicine, which contains the medicine composition consisting of gallnut and scutellaria baicalensis.
[0013] The beneficial effects of the present invention are:
[0014] The combination of Galla chinensis and Scutellaria baicalensis has a synergistic inhibitory effect on multidrug-resistant Escherichia coli and can inhibit the biofilm formation ability of multidrug-resistant Escherichia coli to a certain extent. In addition, the combination of the two can also reduce the resistance of multidrug-resistant Escherichia coli to antibiotics and restore the sensitivity of bacteria to antibiotics, which is beneficial to the prevention and treatment of multidrug-resistant Escherichia coli. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 This is the growth curve of Escherichia coli treated with Galla chinensis and Scutellaria baicalensis;
[0016] Figure 2 This is the growth curve of Escherichia coli treated with Gallnut and Dandelion. DETAILED DESCRIPTION
[0017] At present, there is a lack of effective ways to deal with multi-drug resistant Escherichia coli infections on the market. The present invention first screened a variety of milk-derived Escherichia coli with multi-drug resistance through antibiotics, and used a combined Chinese medicine decoction to treat these multi-drug resistant Escherichia coli. It was found that the combined use of Chinese medicines has a significant synergistic effect on these resistant bacteria, and can reduce their in vitro minimum inhibitory concentration, inhibit the growth of strains and the formation of biofilms, thereby fully proving that the combined use of Chinese medicines has a high feasibility for preventing and treating such multi-drug resistant Escherichia coli.
[0018] Screening test strains with drug-resistant phenotypes and genotypes, the steps are as follows:
[0019] First, raw milk samples were collected from ranches in Shandong Province. Referring to GB 4789.35-2016, 25 mL of raw milk was taken and added to 225 mL of sterilized physiological saline for homogenization. The culture was placed at 37°C for 24 hours, and the culture solution was streaked on crystal violet neutral red bile agar (VRBA) and cultured at 37°C for 24 hours. The typical colonies of Escherichia coli on VRBA plates are purple-red, with red bile salt precipitation rings around the colonies, and the colony diameter is 0.5 mm or larger. The typical single colony on the plate was inoculated on eosin-methylene blue agar (EMB) plates for purification and secondary culture for 24 hours. The typical colonies of Escherichia coli on EMB plates are dark purple-black, smooth, and round colonies with a metallic luster. Suspected strains were selected for biochemical identification, and DNA from the culture solution was extracted and verified by PCR. The identified strains were stored in a -20°C refrigerator for subsequent tests. Through the above experiment, a total of 27 strains of Escherichia coli were isolated from raw milk, numbered from E01 to E27.
[0020] Then, the drug resistance phenotypes of these strains to 15 antibiotics in 8 categories (ampicillin, enrofloxacin, tetracycline, penicillin, gentamicin, florfenicol, kanamycin, polymyxin, streptomycin, cephalexin, amoxicillin, chloramphenicol, ceftriaxone, ciprofloxacin, and cotrimoxazole) were determined. The CLSI Antibiotic Susceptibility Test Standard 2019 version was used for drug sensitivity test, and the drug resistance phenotype was determined by the size of the inhibition zone and the specific standards of each antimicrobial drug. 100 μL of Escherichia coli solution (0.5 McFarland turbidity) was mixed in MH medium (sterilized) at about 50°C and poured onto the plate. After the plate solidified, a drug-sensitive paper was taken with sterile tweezers and attached to the surface of the plate. It was placed in a 37°C incubator for 18-24 hours, and the diameter of the inhibition zone was observed and measured to determine the sensitivity of the isolated strain to the drug (resistant: R; intermediate: I; sensitive: S). Each sample was repeated three times. The results of antibiotic susceptibility assessment of 27 Escherichia coli isolates are shown in Table 1 .
[0021] Table 1 Results of antibiotic susceptibility assessment of Escherichia coli isolates
[0022]
[0023] According to the test results, the most resistant multidrug-resistant Escherichia coli strains E01, E02, E03, and E04 were selected as subsequent test strains, and their resistance phenotypes are shown in Table 2.
[0024] Table 2 Drug resistance phenotypes of multidrug-resistant Escherichia coli isolates
[0025]
[0026]
[0027] The drug resistance spectra of the four multidrug-resistant Escherichia coli isolates screened out are shown in Table 3.
[0028] Table 3 Drug resistance profiles of multidrug-resistant Escherichia coli isolates
[0029] strains Resistance spectrum Drug resistance E01 AMP+PEN+FLO+S+CN+AMX+C+CTR 8 E02 AMP+ENR+TET+PEN+FLO+S+CN+C+CTR+CIP+SXT 11 E03 AMP+ENR+TET+PEN+GEN+FLO+KAN+S+CN+AMX+C+CTR+CIP+SXT 14 E04 AMP+PEN+PB+S+CN+AMX+CTR 7
[0030] Finally, DNA of four multidrug-resistant E. coli strains was extracted, and the coding of blaTEM, blaCTX-M, blaSHV, tet(A), sul-1, floR, and gyrA resistance genes was determined by PCR and agarose gel electrophoresis. PCR amplification was performed using a 20 μL system, and the test results were obtained by photographing with a gel imager. The specific coding resistance genotypes are shown in Table 4.
[0031] Table 4 Genotypes encoding drug resistance in Escherichia coli strains
[0032] strains Drug resistance genotype E01 blaCTX-M, blaTEM, blaSHV, tet(A), sul-1, floR, gyrA E02 blaCTX-M, blaTEM, blaSHV, tet(A), sul-1, gyrA E03 blaCTX-M, blaTEM, blaSHV, tet(A), sul-1, floR, gyrA E04 blaCTX-M, blaTEM, blaSHV, tet(A), sul-1, floR, gyrA
[0033] Based on the above experimental results, four multidrug-resistant Escherichia coli (E01, E02, E03, and E04) containing β-lactamase encoding genes and the highest resistance weight were selected from the measured strains as subsequent test strains for drug activity testing.
[0034] The present invention is further described in detail below in conjunction with specific embodiments and with reference to data, and the described embodiments are only a part of embodiments of the present invention, rather than all embodiments. The experimental methods used in the following embodiments are conventional methods unless otherwise specified. The materials, reagents, etc. used in the following embodiments, unless otherwise specified, can be obtained through commercial channels. Other terms used in the present invention, unless otherwise specified, generally have the meanings commonly understood by those of ordinary skill in the art. The following examples are only for illustrating the present invention, and are not intended to limit the scope of the present invention in any way.
[0035] Example Galla Chinensis and Scutellaria Baicalensis Combined Use
[0036] 1. Determination of the combined effect of Galla chinensis and Scutellaria baicalensis
[0037] The in vitro antibacterial activities of Galla chinensis and Scutellaria baicalensis when used alone and in combination were determined as follows:
[0038] (1) Preparation of Chinese medicine decoction (stock solution)
[0039] Accurately weigh 50 g of each of the Chinese medicine Galla chinensis and Scutellaria baicalensis, grind them, soak them in 500 mL of distilled water for 4 h, boil them with high heat first, then keep them in a slightly boiling state with low heat, boil them for 30 min, and filter them with gauze; add 500 mL of distilled water to the residue, boil them for 30 min, and filter them with gauze; combine the two medicinal liquids and then cook them with low heat to concentrate them to 50 mL, until the final concentration of the medicinal liquid is 1000 mg / mL, filter them through a 0.22 μm filter membrane, sterilize them under high pressure at 110°C for 20 min, and store them in a 4°C refrigerator for later use.
[0040] (2) Preparation of Escherichia coli culture solution
[0041] Four multidrug-resistant E. coli strains E01, E02, E03 and E04 were selected. The above-mentioned drug-resistant strains were streaked onto EMB plates and incubated upside down at 37°C overnight. A single colony was picked and inoculated into LB broth medium and shaken at 37°C overnight.
[0042] (3) Determination of the minimum inhibitory concentration of Galla chinensis and Scutellaria baicalensis against Escherichia coli
[0043] A 96-well culture plate was used for microbroth dilution method. A sterile 96-well plate was placed in a clean bench. The different concentrations of Gallic acid after multiple dilution were added from left to right to the 96-well plate. 100 μL was added to each well. The final concentrations of Gallic acid in the first to tenth columns were 0.06, 0.12, 0.24, 0.49, 0.98, 1.95, 3.9, 7.8, 15.625, and 31.25 mg / mL. The different concentrations of Scutellaria baicalensis after multiple dilution were added from left to right to the 96-well plate. 100 μL was added to each well. The final concentrations of Scutellaria baicalensis in the first to tenth columns were 1.95, 3.9, 7.8, 15.625, 31.25, 62.5, 125, 250, 500, and 1000 mg / mL. Add 100 μL of bacterial solution to each well from the first to the tenth column, and the final concentration of bacteria in each well is 1×10 5 CFU / mL. Add 200μL of bacterial solution to the eleventh column as a positive control, and add 200μL of broth to the twelfth column as a negative control. Perform three parallel tests for each strain of bacteria and each Chinese medicine. Incubate at 37℃ for 16-24h, and observe and record the results when the eleventh column is turbid and the twelfth column is clear. Read the lowest drug concentration at which no bacteria grow, which is the minimum inhibitory concentration of bacteria for the drug.
[0044] (4) Determination of the minimum inhibitory concentration of Galla chinensis combined with Scutellaria baicalensis against Escherichia coli
[0045] According to the results of the single drug minimum inhibitory concentration, 6 dilution gradients were taken for combined drug sensitivity test. The different concentrations of Gallic acid after multiple dilution were added to the 96-well plate from low to high from left to right, and 50 μL was added to each well. The final concentrations of Gallic acid in the first to sixth columns were 0.06, 0.12, 0.24, 0.49, 0.98, and 1.95 mg / mL, respectively. The different concentrations of Scutellaria baicalensis after multiple dilution were added to the 96-well plate from low to high from top to bottom, and 50 μL was added to each well. The final concentrations of Scutellaria baicalensis in the first to sixth rows were 7.8, 15.625, 31.25, 62.5, 125, and 250 mg / mL, respectively. 100 μL of bacterial solution was added to each well in the first to sixth columns, so that the final concentration of bacteria in each well was 1×10 5 CFU / m, the drug concentration is shown in Table 5. Add 200 μL of bacterial solution to the seventh column as a positive control, and add 200 μL of broth to the eighth column as a negative control. Incubate at 37°C for 16-24 hours, and read the minimum inhibitory concentration value when the seventh column is turbid and the eighth column is clear.
[0046] Table 5 Determination of drug combination concentration by chessboard method
[0047]
[0048] (5) Calculation of fractional inhibitory concentration index (FICI)
[0049] The minimum inhibitory concentration of the composition was determined based on the results of the chessboard method, and the graded inhibitory concentration index of each strain was calculated to classify the antibacterial synergistic effect of the composition.
[0050] FICI is used as the basis for judging the results of the combined drug sensitivity test. The calculation method of the graded inhibitory concentration index is: FICI = MIC drug A (combination) / MIC drug A alone + MIC drug B (combination) / MIC drug B alone. Among them, FICI ≤ 0.5 indicates synergistic effect; 0.5 < FICI ≤ 1 indicates additive effect; 1 < FICI ≤ 2 indicates irrelevant effect; FICI > 2 indicates antagonistic effect.
[0051] The test results are shown in Table 6:
[0052] Table 6 Synergistic effect results of Galla Chinensis and Scutellaria Baicalensis
[0053]
[0054] As shown in Table 6, the combination of Galla chinensis and Scutellaria baicalensis has a synergistic inhibitory effect on four strains of multidrug-resistant Escherichia coli.
[0055] 2. Drug combination antibacterial test
[0056] (1) Determination of antibacterial effect
[0057] According to the results of the chessboard dilution method, isolate E03 was selected for drug combination antibacterial test, and the drug combination of 0.12 mg / mL Galla chinensis and 31.25 mg / mL Scutellaria baicalensis was used for the test. 5 CFU / mL, the combined Chinese medicine group was added with a Chinese medicine combination of 0.12mg / mL gallnut and 31.25mg / mL scutellaria baicalensis; the single drug group was added with a final concentration of 1.95mg / mL gallnut and a final concentration of 125mg / mL scutellaria baicalensis; the positive control group was replaced with an equal amount of bacterial solution, and the negative control group was replaced with an equal amount of sterile water. Three parallel tests were performed for each Chinese medicine. Incubate at 37°C and measure the absorbance value at A=600nm every 2h.
[0058] The results of the test are as follows Figure 1 As shown:
[0059] Compared with the positive control group, the OD 600 The value decreased significantly, indicating that the combination of Galla chinensis and Scutellaria baicalensis had a very significant inhibitory effect on Escherichia coli.
[0060] (2) Biofilm formation ability assay
[0061] The biofilm formation ability of bacteria E03 was detected by crystal violet staining. 100 μL of 1×10 6 CFU / mL of bacterial solution, the combined Chinese medicine group added 100μL of a drug combination of 0.12mg / mL Galla chinensis and 31.25mg / mL Scutellaria baicalensis at a final concentration, and 200μL of LB broth culture medium without bacterial solution was used as a negative control, and each combination was paralleled in 3 groups. The 96-well plate was placed at 37℃ for 18-24h. The upper floating bacteria were aspirated, washed lightly with PBS 3 times, and 200μL of 1% crystal violet stain was added to each well after drying. After standing for 30min, the stain was aspirated, and then washed lightly with PBS 3 times. After drying, 200μL of anhydrous ethanol was added to each well for decolorization for 20min, and the absorbance value at A=590nm was measured, and the average value was taken after 3 times.
[0062] The test results are shown in Table 7:
[0063] Table 7 Escherichia coli biofilm formation
[0064] strains <![CDATA[OD 590 ]]> Biofilm formation ability Untreated strains 0.2653 middle Gallnut + Scutellaria baicalensis 0.2127 weak
[0065] OD in the combined Chinese medicine group 590The value decreased, and the biofilm formation ability changed from medium to weak. Therefore, the combination of Galla chinensis and Scutellaria baicalensis had an inhibitory effect on the biofilm formation of Escherichia coli.
[0066] 3. Drug resistance elimination test
[0067] The drug resistance phenotype changes of the strains after elimination by the Chinese medicine combination were compared to further confirm the recovery effect of antibiotic sensitivity after the elimination of Escherichia coli resistance. The drug resistance phenotypes of the E03 strains treated with the Chinese medicine combination (0.12 mg / mL Galla chinensis + 31.25 mg / mL Scutellaria baicalensis) to ampicillin, penicillin, ceftriaxone, cephalexin, amoxicillin, tetracycline, and polymyxin were determined, and the drug resistance phenotype changes of the untreated E03 strains were compared by the size of the inhibition zone and the specific standards of each antibacterial drug. 100 μL of bacterial solution (0.5 McFarland turbidity) was mixed in MH medium (sterilized) at about 50°C and poured into a plate. After the plate solidified, a drug-sensitive paper was taken with sterile tweezers and attached to the surface of the plate, and it was placed in a 37°C incubator for 18-24 hours. The diameter of the inhibition zone was observed and measured to determine the sensitivity of the multi-drug resistant Escherichia coli strains to drugs (resistant: R; intermediate: I; sensitive: S).
[0068] The changes in drug resistance phenotypes of Escherichia coli isolates are shown in Table 8:
[0069] Table 8 Changes in drug resistance phenotypes of multidrug-resistant Escherichia coli
[0070]
[0071]
[0072] After the strains were treated with the Chinese medicine composition, the diameter of the inhibition zone of antibiotics showed an increasing trend, especially for β-lactamase drugs. Therefore, the combination of Galla chinensis and Scutellaria baicalensis can increase the sensitivity of multidrug-resistant bacteria to antibiotics.
[0073] 4. Drug resistance gene elimination experiment
[0074] DNA of multidrug-resistant Escherichia coli strains treated with traditional Chinese medicine was extracted, and the coding of blaTEM, blaCTX-M, blaSHV, tet(A), sul-1, floR, and gyrA resistance genes was determined by PCR and agarose gel electrophoresis. DNA of Escherichia coli was extracted by boiling method, PCR amplification was performed using 20uL system, and the test results were obtained by gel imaging.
[0075] The specific changes in drug-resistant genotypes are shown in Table 9:
[0076] Table 9 Drug-resistant genotypes of multidrug-resistant Escherichia coli after treatment with Chinese medicine combination
[0077] strains Drug resistance genotype E01 blaCTX-M, blaSHV, tet(A), sul-1, floR, gyrA E02 blaCTX-M, blaSHV, tet(A), sul-1, gyrA E03 blaCTX-M, tet(A), sul-1, floR, gyrA E04 blaCTX-M, tet(A), sul-1, floR, gyrA
[0078] As shown in Table 8, after the strains were treated with the Chinese medicine combination, the drug-resistant genes encoded were eliminated or the bands were weakened, especially the resistance genes of β-lactamases. No blaTEM was detected in the strains treated with the Chinese medicine combination.
[0079] 5. Elimination experiment
[0080] E03 was selected for the test of eliminating the Chinese medicine composition of gallnut and scutellaria (0.12mg / mL gallnut + 31.25mg / mL scutellaria). The mixture of gallnut and scutellaria was mixed with E03 for culture, and the E03 strain was treated with 0.02% SDS as the elimination control group, and the E03 strain was treated with the same amount of sterile water as the negative control group. Cultured at 37°C for 24h, 48h, and 72h. The cultured bacterial solution was fully diluted and applied to the LB agar plate, and cultured at 37°C for 12-18h to obtain a large number of single colonies. 100 single colonies were picked from each plate and spotted on the LB agar plate and the LB agar plate containing Chinese medicine, and inverted and cultured at 37°C for 12h. The colonies that did not grow on the plate containing Chinese medicine and the plate without Chinese medicine were selected and inoculated again on the culture medium containing Chinese medicine for verification. If there was no growth, the colony was an eliminater (strain with drug resistance eliminated).
[0081] The test results are shown in Table 10:
[0082] Table 10 Elimination test results of multi-drug resistant Escherichia coli
[0083]
[0084]
[0085] Within 72 hours after multidrug-resistant Escherichia coli was treated with the combination, the number of resistant eliminaters was proportional to the culture time and increased with the extension of culture time. The number of eliminaters obtained in the combined Chinese medicine group was significantly greater.
[0086] The combination of Galla chinensis and Scutellaria baicalensis has a synergistic inhibitory effect on four strains of multidrug-resistant Escherichia coli, and can inhibit the biofilm formation ability of multidrug-resistant Escherichia coli to a certain extent. The combination of Galla chinensis and Scutellaria baicalensis can reduce the resistance phenotype and genotype of multidrug-resistant bacteria to antibiotics.
[0087] Comparative Example 1: Use of Galla Chinensis and Scutellaria Baicalensis as Single Drugs
[0088] 1. Single drug antibacterial test
[0089] (1) Preparation of Chinese medicine decoction (stock solution)
[0090] Accurately weigh 50 g of each of the Chinese medicine Galla chinensis and Scutellaria baicalensis, grind them, soak them in 500 mL of distilled water for 4 h, boil them with high heat first, then keep them in a slightly boiling state with low heat, boil them for 30 min, and filter them with gauze; add 500 mL of distilled water to the residue, boil them for 30 min, and filter them with gauze; combine the two medicinal liquids and then cook them with low heat to concentrate them to 50 mL, until the final concentration of the medicinal liquid is 1000 mg / mL, filter them through a 0.22 μm filter membrane, sterilize them under high pressure at 110°C for 20 min, and store them in a 4°C refrigerator for later use.
[0091] (2) Preparation of Escherichia coli culture solution
[0092] Select multidrug-resistant Escherichia coli E03. Streak the above-mentioned drug-resistant strains on EMB plates and incubate them upside down at 37°C overnight. Pick a single colony and inoculate it in LB broth medium, and shake it at 37°C overnight.
[0093] (3) Biofilm formation ability assay
[0094] The biofilm formation ability of bacteria E03 was detected by crystal violet staining. 100 μL of 1×10 6 CFU / mL of bacterial solution, the single drug treatment groups were Galla chinensis with a final concentration of 1.95mg / mL and Scutellaria baicalensis with a final concentration of 125mg / mL, and 200μL LB broth culture medium without bacterial solution was used as a negative control, and 3 groups were parallel for each treatment. The 96-well plate was placed at 37℃ for 18-24h. The upper floating bacteria were aspirated, washed lightly with PBS 3 times, and 200μL 1% crystal violet stain was added to each well after drying. After standing for 30min, the stain was aspirated, and then washed lightly with PBS 3 times. After drying, 200μL of anhydrous ethanol was added to each well for decolorization for 20min, and the absorbance value at A=590nm was measured, and the average value was taken after 3 times.
[0095] The test results are shown in Table 11:
[0096] Table 11 Escherichia coli biofilm formation
[0097]
[0098]
[0099] Compared with the untreated group, the biofilm forming ability of the strains treated with Galla chinensis and Scutellaria baicalensis alone remained basically unchanged.
[0100] 2. Drug resistance elimination test
[0101] The drug resistance phenotype of E03 strains in the single-drug treatment group to ampicillin, penicillin, ceftriaxone, cephalexin, amoxicillin, tetracycline, and polymyxin was determined, and the resistance phenotype of untreated E03 strains was compared by the size of the inhibition zone and the specific standards of each antimicrobial drug. The single-drug treatment groups were respectively treated with Galla chinensis with a final concentration of 1.95 mg / mL and Scutellaria baicalensis with a final concentration of 125 mg / mL. 100 μL of bacterial solution (0.5 McFarland turbidity) was mixed in MH medium (sterilized) at about 50°C and poured into a plate. After the plate solidified, a drug-sensitive paper was taken with sterile tweezers and attached to the surface of the plate. It was placed in a 37°C incubator for 18-24 hours, and the diameter of the inhibition zone was observed and measured to determine the sensitivity of multidrug-resistant Escherichia coli strains to drugs (resistant: R; intermediate: I; sensitive: S).
[0102] The test results are shown in Table 12:
[0103] Table 12 Changes in drug resistance phenotype of multidrug-resistant Escherichia coli
[0104]
[0105] After the strains were treated with a single drug, the diameter of the antibiotic's inhibition zone did not change much, and it had no effect on increasing the sensitivity of multidrug-resistant bacteria to antibiotics.
[0106] 3. Drug resistance gene elimination experiment
[0107] DNA of multidrug-resistant Escherichia coli strains treated with a single drug was extracted, and the coding of blaTEM, blaCTX-M, blaSHV, tet(A), sul-1, mcr-1, floR, and gyrA resistance genes was determined by PCR and agarose gel electrophoresis. DNA of Escherichia coli was extracted by boiling method, PCR amplification was performed using 20uL system, and the test results were obtained by gel imaging.
[0108] After the strains were treated with a single drug, there was no elimination effect on the genes encoding drug resistance, and all drug resistance genes were detected.
[0109] 4. Elimination experiment
[0110] In the test of the elimination of gallnut and scutellaria baicalensis alone, gallnut (1.95 mg / mL), scutellaria baicalensis (125 mg / mL) and E03 were mixed and cultured, and the E03 strain was treated with 0.02% SDS as the elimination control group, and the E03 strain was treated with the same amount of sterile water as the negative control group. Cultured at 37℃ for 24h, 48h, and 72h. The cultured bacterial solution was fully diluted and applied to the LB agar plate, and cultured at 37℃ for 12-18h to obtain a large number of single colonies. 100 single colonies were picked from each plate and spotted on the LB agar plate and the LB agar plate containing Chinese medicine, and inverted and cultured at 37℃ for 12h. The colonies that did not grow on the plate containing Chinese medicine and the plate without Chinese medicine were selected and inoculated again on the culture medium containing Chinese medicine for verification. If there was no growth, the colony was an elimination (strain with drug resistance eliminated).
[0111] The test results are shown in Table 13:
[0112] Table 13 Elimination test results of multi-drug resistant Escherichia coli
[0113]
[0114] Based on the comprehensive test results, the single-drug treatment group's effect on eliminating multidrug-resistant Escherichia coli is obviously not as good as the effect when the two drugs are used in combination.
[0115] Comparative Example 2: Combination of Gallnut and Taraxacum officinale
[0116] 1. Determination of the combined effect of Galla chinensis and Dandelion
[0117] The in vitro antibacterial activities of Galla chinensis and Taraxacum officinale when used alone and in combination were determined as follows:
[0118] (1) Preparation of Chinese medicine decoction (stock solution)
[0119] Accurately weigh 50 g of each of the Chinese medicine Galla chinensis and Taraxacum officinale, grind them, soak them in 500 mL of distilled water for 4 h, boil them with high heat first, then keep them in a slightly boiling state with low heat, boil them for 30 min, and filter them with gauze; add 500 mL of distilled water to the residue, boil them for 30 min, and filter them with gauze; combine the two medicinal liquids and then cook them with low heat to concentrate them to 50 mL, until the final concentration of the medicinal liquid is 1000 mg / mL, filter them through a 0.22 μm filter membrane, sterilize them under high pressure at 110°C for 20 min, and store them in a 4°C refrigerator for later use.
[0120] (2) Preparation of Escherichia coli culture solution
[0121] The four multidrug-resistant E. coli strains E01, E02, E03 and E04 were streaked onto EMB plates and incubated overnight at 37°C. A single colony was picked and inoculated into LB broth medium and shaken at 37°C overnight.
[0122] (3) Determination of the minimum inhibitory concentration of gallnut and dandelion against Escherichia coli
[0123] The 96-well culture plate was used for microbroth dilution method. The sterile 96-well plate was placed in the clean bench. The different concentrations of gallnut after multiple dilution were added from low to high from left to right to the 96-well plate, and 100 μL was added to each well. The final concentrations of gallnut in the first to tenth columns were 0.06, 0.12, 0.24, 0.49, 0.98, 1.95, 3.9, 7.8, 15.625, and 31.25 mg / mL. The different concentrations of dandelion after multiple dilution were added from low to high from left to right to the 96-well plate, and 100 μL was added to each well. The final concentrations of dandelion in the first to tenth columns were 1.95, 3.9, 7.8, 15.625, 31.25, 62.5, 125, 250, 500, and 1000 mg / mL. Add 100 μL of bacterial solution to each well from the first to the tenth column, and the final concentration of bacteria in each well is 1×10 5 CFU / mL. Add 200μL of bacterial solution to the eleventh column as a positive control, and add 200μL of broth to the twelfth column as a negative control. Perform three parallel tests for each strain of bacteria and each Chinese medicine. Incubate at 37℃ for 16-24h, and observe and record the results when the eleventh column is turbid and the twelfth column is clear. Read the lowest drug concentration at which no bacteria grow, which is the minimum inhibitory concentration of bacteria for the drug.
[0124] (4) Determination of the minimum inhibitory concentration of Galla chinensis combined with Dandelion against Escherichia coli
[0125] According to the results of the minimum inhibitory concentration of a single drug, 6 dilution gradients were taken for combined drug sensitivity testing. The different concentrations of gallnut after multiple dilution were added to the 96-well plate from low to high from left to right, and 50 μL was added to each well. The final concentrations of gallnut in the first to sixth columns were 0.12, 0.24, 0.49, 0.98, 1.95, and 3.9 mg / mL, respectively. The different concentrations of dandelion after multiple dilution were added to the 96-well plate from low to high from top to bottom, and 50 μL was added to each well. The final concentrations of dandelion in the first to sixth rows were 15.625, 31.25, 62.5, 125, 250, and 500 mg / mL, respectively. 100 μL of bacterial solution was added to each well in the first to sixth columns, so that the final concentration of bacteria in each well was 1×10 5 CFU / m, the drug concentration is shown in Table 14. Add 200 μL of bacterial solution to the seventh column as a positive control, and add 200 μL of broth to the eighth column as a negative control. Incubate at 37°C for 16-24 hours, and read the minimum inhibitory concentration value when the seventh column is turbid and the eighth column is clear.
[0126] Table 14 Determination of drug combination concentration by chessboard method
[0127]
[0128] (5) Calculation of fractional inhibitory concentration index (FICI)
[0129] The minimum inhibitory concentration of the combination was determined based on the results of the checkerboard method, and the graded inhibitory concentration index for each strain was calculated for classification of the antibacterial synergy of the combination.
[0130] The calculation method of graded inhibitory concentration index is: FICI = MIC drug A (combination) / MIC drug A alone + MIC drug B (combination) / MIC drug B alone. Among them, FICI ≤ 0.5 indicates synergistic effect; 0.5 < FICI ≤ 1 indicates additive effect; 1 < FICI ≤ 2 indicates irrelevant effect; FICI > 2 indicates antagonistic effect.
[0131] The test results are shown in Table 15:
[0132] Table 15 Synergistic effect results of Galla chinensis and Taraxacum officinale
[0133]
[0134] As shown in Table 15, the combination of Gallnut and Taraxacum officinale had no effect on the three strains of multidrug-resistant Escherichia coli, but had an additive effect on E04.
[0135] 2. Drug combination antibacterial test
[0136] (1) Determination of antibacterial effect
[0137] According to the results of the chessboard dilution method, isolate E04 was subsequently selected for drug combination antibacterial test, and a combination of 0.12 mg / mL Galla chinensis and 125 mg / mL Taraxacum officinale was used for the test. 5 CFU / mL, the combined Chinese medicine group was added with a Chinese medicine combination of 0.12mg / mL gallnut and 125mg / mL dandelion; the single drug group was added with a final concentration of 0.49mg / mL gallnut and a final concentration of 250mg / mL dandelion; the positive control group was replaced with an equal amount of bacterial solution, and the negative control group was replaced with an equal amount of sterile water. Three parallel tests were performed for each Chinese medicine. Incubated at 37°C, the absorbance value at A=600nm was measured every 2h.
[0138] The results of the test are as follows Figure 2 As shown:
[0139] Compared with the positive control group, the OD 600The value was slightly reduced; compared with the single drug group, the OD 600 The values were not significantly different from those of the Chinese medicine group containing gallnut, and the combination of gallnut and dandelion had no significant inhibitory effect on Escherichia coli.
[0140] (2) Biofilm formation ability assay
[0141] The biofilm formation ability of bacteria E04 was detected by crystal violet staining. 100 μL of 1×10 6 CFU / mL of bacterial solution, 100μL of gallnut with a final concentration of 0.49mg / mL and dandelion with a final concentration of 250mg / mL were added to the single drug group; 100μL of a drug combination of gallnut with a final concentration of 0.12mg / mL and dandelion with a final concentration of 125mg / mL was added to the combined Chinese medicine group, and 200μL of LB broth culture medium without bacterial solution was used as a negative control, and each sample was repeated 3 times. The 96-well plate was placed at 37℃ for 18-24h. The upper floating bacteria were aspirated, washed lightly with PBS 3 times, and 200μL of 1% crystal violet staining solution was added to each well after drying. After standing for 30min, the staining solution was aspirated, and then washed lightly with PBS 3 times. After drying, 200μL of anhydrous ethanol was added to each well for decolorization for 20min, and the absorbance value at A=590nm was measured, and the average value was taken after 3 times.
[0142] The test results are shown in Table 16:
[0143] Table 16 Escherichia coli biofilm formation
[0144]
[0145]
[0146] Compared with the single drug treatment group, the OD 590 The values did not change or even increased, and the biofilm formation ability was judged to be medium. The combination of gallnut and dandelion had no inhibitory effect on the biofilm formation of Escherichia coli, but enhanced it.
[0147] 3. Drug resistance elimination test
[0148] The drug resistance phenotype changes of the strains eliminated by the Chinese medicine combination were compared to further confirm the recovery effect of antibiotic sensitivity after the elimination of Escherichia coli resistance. The drug resistance phenotypes of the E04 strains treated with the Chinese medicine combination to ampicillin, penicillin, ceftriaxone, cephalexin, amoxicillin, tetracycline, and polymyxin were determined, and the drug resistance phenotype changes of the untreated E04 strains were compared by the size of the inhibition zone and the specific standards of each antibacterial drug. 100 μL of Escherichia coli liquid (0.5 McFarland turbidity) was mixed in MH medium (sterilized) at about 50°C and poured into a plate. After the plate solidified, a drug-sensitive paper was taken with sterile tweezers and attached to the surface of the plate. It was placed in a 37°C incubator for 18-24 hours, and the diameter of the inhibition zone was observed and measured to determine the sensitivity of the multi-drug resistant Escherichia coli strains to drugs (resistant: R; intermediate: I; sensitive: S).
[0149] The changes in drug resistance phenotypes of Escherichia coli isolates are shown in Table 17:
[0150] Table 17 Changes in drug resistance phenotype of multidrug-resistant Escherichia coli
[0151]
[0152] From Table 17, it can be seen that after the strains were treated with the Chinese medicinal composition of Galla chinensis and Taraxacum officinale, the diameter of the antibiotic inhibition zone was slightly affected, the resistance to penicillin and amoxicillin was slightly reduced, and the resistance to other antibiotics was almost not affected.
[0153] 4. Drug resistance gene elimination experiment
[0154] DNA of multidrug-resistant Escherichia coli strains was extracted, and the coding of blaTEM, blaCTX-M, blaSHV, tet(A), sul-1, floR, and gyrA resistance genes was determined by PCR and agarose gel electrophoresis. DNA of Escherichia coli was extracted by boiling method, PCR amplification was performed using 20uL system, and the test results were obtained by gel imaging.
[0155] The specific changes in drug-resistant genotypes are shown in Table 18:
[0156] Table 18 Drug-resistant genotypes of multidrug-resistant Escherichia coli after treatment with Chinese medicine combination
[0157] strains Drug resistance genotype E01 blaCTX-M, blaTEM, blaSHV, tet(A), sul-1, floR, gyrA E02 blaCTX-M, blaTEM, blaSHV, tet(A), sul-1, gyrA E03 blaCTX-M, blaTEM, blaSHV, tet(A), sul-1, floR, gyrA E04 blaCTX-M, blaTEM, blaSHV, tet(A), sul-1, floR, gyrA
[0158] From Table 17, it can be seen that after the strain was treated with the Chinese medicinal composition of Galla chinensis and Taraxacum officinale, there was no elimination effect on the genes encoding drug resistance, and all drug resistance genes were still detected.
[0159] 5. Elimination experiment
[0160] E04 was selected for the test of eliminating the gallnuts with Chinese medicinal composition of dandelion. Gallnuts and dandelion (0.12mg / mL gallnuts + 125mg / mL dandelion), gallnuts (0.49mg / mL), dandelion (250mg / mL) were mixed and cultured with E04, and the E04 strain was treated with 0.02% SDS as the elimination control group, and the E04 strain was treated with the same amount of sterile water as the negative control group. The strains were cultured at 37°C for 24h, 48h, and 72h. The cultured bacterial solution was fully diluted and applied to LB agar plates, and cultured at 37°C for 12-18h to obtain a large number of single colonies. 100 single colonies were picked and dotted on LB agar plates and LB agar plates containing elimination agents, and inverted and cultured at 37°C for 12h. Select the colonies that do not grow on the drug-containing plate and grow on the drug-free plate, and inoculate them again on the drug-containing culture medium for verification. If there is no growth, the colony is an eliminated strain (a strain with drug resistance eliminated).
[0161] The test results are shown in Table 19:
[0162] Table 19 Elimination test results of drug-resistant Escherichia coli
[0163]
[0164] The test results showed that compared with the control group, the Chinese herbal combination of gallnut and dandelion had no effect on the formation of biofilm, nor did it eliminate the resistance phenotype and genotype of multidrug-resistant Escherichia coli.
[0165] The above results show that the effect of Galla chinensis or Scutellaria baicalensis decoction alone on reducing the drug resistance of drug-resistant Escherichia coli is poor, but the combination of the two has a good synergistic effect. The combination of Galla chinensis and Scutellaria baicalensis has a synergistic inhibitory effect on four strains of multidrug-resistant Escherichia coli, and can inhibit the biofilm formation ability of multidrug-resistant Escherichia coli to a certain extent, and reduce the resistance phenotype and genotype of multidrug-resistant bacteria to antibiotics.
[0166] The above is only a preferred embodiment of the present invention, and does not limit the present invention in other forms. Any technician familiar with the profession may use the above disclosed technical content to change or modify it into an equivalent embodiment with equivalent changes. However, any simple modification, equivalent change and modification made to the above embodiment according to the technical essence of the present invention without departing from the technical solution of the present invention still belongs to the protection scope of the technical solution of the present invention.
Claims
1. A pharmaceutical composition for inhibiting Escherichia coli, characterized in that: The composition consists of gallnut and scutellaria baicalensis.
2. The pharmaceutical composition according to claim 1, characterized in that The mass ratio of the Chinese gallnut to the scutellaria baicalensis is selected from 0.12-0.49:7.8-62.
5.
3. The pharmaceutical composition according to claim 2, characterized in that The mass ratio of the Chinese gallnut to the scutellaria baicalensis is selected from 0.12:7.8, 0.12:31.25, 0.12:62.5 or 0.49:31.
25.
4. Use of the pharmaceutical composition according to any one of claims 1 to 3 in the preparation of a drug for synergistic inhibition of Escherichia coli.
5. The use according to claim 4, characterized in that: The Escherichia coli is a multidrug-resistant Escherichia coli, preferably an Escherichia coli resistant to β-lactams, amidoalcohols, quinolones, aminoglycosides, sulfonamides, tetracyclines, polymyxins or chloramphenicol antibiotics.
6. The use according to claim 5, characterized in that: The multidrug-resistant Escherichia coli is milk-derived multidrug-resistant Escherichia coli.
7. Use of the pharmaceutical composition according to any one of claims 1 to 3 in the preparation of a drug for synergistically inhibiting the formation of Escherichia coli biofilm.
8. Use of the pharmaceutical composition according to any one of claims 1 to 3 in the preparation of a drug for reducing or eliminating drug resistance of Escherichia coli.
9. Use of the pharmaceutical composition according to any one of claims 1 to 3 in the preparation of a drug for increasing the sensitivity of Escherichia coli to antibiotics.
10. The use according to claim 9, characterized in that: The antibiotic is selected from the group consisting of β-lactams, amidoalcohols, quinolones, aminoglycosides, sulfonamides, tetracyclines, polymyxins or chloramphenicol antibiotics.
Citation Information
Patent Citations
Traditional Chinese medicine for controlling aeromonas hydrophila disease of aquatic animals and utilizing method thereof
CN102240323A
Scutellaria baicalensis decoction as synergist of ceftiofur and application thereof
CN116898895A
Cited By
Composition for synergistically inhibiting klebsiella pneumoniae and application thereof
CN118873562A
